A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis

Liver International

Volumn 24, Issue 2, 2004, Pages 169-176

  Bruck, Rafael ^a,b   Schey, Ron ^a,b   Aeed, Hussein ^a,b   Hochman, Ayala ^b   Genina, Olga ^c   Pines, Mark ^c  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c VOLCANI CENTER   (Israel)

Author keywords

Liver cirrhosis; Nuclear factor kappa B; Thioacetamide

Indexed keywords

ALPHA ACTIN; CARBONYL DERIVATIVE; COLLAGEN; PYRROLIDINE DITHIOCARBAMATE; THIOACETAMIDE DERIVATIVE; THIOBARBITURIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; LIVER CIRRHOSIS; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SCORING SYSTEM; SMOOTH MUSCLE; SPLEEN WEIGHT; STELLATE CELL;

EID: 2342558077     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.00900.x     Document Type: Article

References (56)

1. Bissel D M, Friedman S L, Maher J J, Roll F J. Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology 1990; 11: 488-98.
2. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994; 10: 405-55.
3. Baeuerle P A, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141-79.
4. Collins T, Read M A, Neish A S, Whitley M Z, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995; 899-909.
5. Hellerbrand C, Jobin C, Licato L L, Sartor R B, Brenner D A. Cytokines induce NF-kappa B in activated but in quiescent rat hepatic stellate cells. Am J Physiol 1998; 275: G269-78.
6. Lee K S, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myc expression. J Clin Invest 1995; 96: 2461-8.
7. Hellerbrand C, Wang S C, Tsukamoto H, Brenner D A, Rippe R A. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 1996; 24: 670-6.
8. Hellerbrand C, Jobin C, Limuro Y, Licato L L, Sartor R B, Brenner D A. Inhibition of NF-kappa B in activated rat hepatic stellate cells by proteasome inhibitors and an I-kappa B super-repressor. Hepatology 1998; 27: 1285-95.
9. Gallois C, Habib A, Tao J, Moulin S, Maclouf J, Mallat A, Lotersztajn S. Role of NF-kappa B in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem 1998; 273: 23183-90.
10. Taub R. Blocking NF-kappa B in the liver: the good and the bad news [editorial; comment]. Hepatology 1998; 27: 1445-6.
11. Lu S C, Huang Z Z, Yang H, Tsukamoto H. Effect of thioacetamide on the hepatic expression of gamma-glutamylcysteine synthetase subunits in the rat. Toxicol Appl Pharmacol 1999; 159(3): 161-8.
12. Muller D, Sommer M, Kretzschmar M, Zimmermann T, Buko V U, Lukivskaya O J, Dargel R. Lipid peroxidation in thioacetamide-induced macronodular rat liver cirrhosis. Toxicology 1991; 65: 199-203.
13. Bruck R, Aeed H, Schey R, Matas Z, Raifen R, Zaiger G, Hochman A, Avni Y. Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats. J Hepatol 2002; 36: 370-7.
14. Schreck R, Meier B, Mannel D N, Droge W, Baeuerle P A. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 1992; 175: 1181-94.
15. Hori N, Okanoue T, Sawa Y, Mori T, Kashima K. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration. Dig Dis Sci 1993; 38: 2195-202.
16. Muller A, Machnik F, Zimmermann T, Schubert H. Thioacetamide-induced cirrhosis-like lesions in rats - usefulness and reliability of this animal model. Exp Pathol 1988; 34: 229-36.
17. Gascon-Barre M, Huet P M, Belgiorno J, Plourde V, Coulomb P A. Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats. J Histochem Cytochem 1989; 37: 377-81.
18. Pines M, Knopov V, Genina O, Lavelin I, Nagler A. Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis. J Hepatol 1997; 27: 391-8.
19. Woessner J F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93: 440-7.
20. Niehaus W G, Samuelsson J R, Wills E D. Lipid peroxide formation in microsomes. Biochem J 1969; 113: 315-41.
21. Buss H, Chan T P, Sluis K B, Domigan N M, Winter-Bourn C. Protein carbonyl measurement by a sensitive ELISA method. Free Rad Biol Med 1997; 23: 361-6.
22. Slater T F. Free radical mechanisms in tissue injury. Biochem J 1984; 222: 1-15.
23. Machlin L J, Bendich A. Free radical tissue damage: protective role of anti oxidant nutrients. FASEB J 1987; 1: 441-5.
24. Bacon B R, Tavill A T, Brittenham G M, Park C H, Recknagel R O. Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 1983; 71: 429-39.
25. Kyle M E, Miccadei S, Nakae D, Farber J L. Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen. Biochem Biophys Res Commun 1987; 149: 889-96.
26. Shaw S, Jayatilleke E, Ross W A, Gordon E, Lieber C S. Ethanol induced lipid peroxidation: potentiation by long-term alcohol feeding and attenuation by methionine. J Lab Clin Med 1981; 417-25.
27. s+: activation of NF-κB, selective inhibition of antioxidants and integral membrane localization. EMBO J 1993; 11: 2991-8.
28. 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am J Physiol 1994; 267: G908-13.
29. Brenner D A, Chojkier M. Acetaldehyde increases collagen gene transcription in cultured human fibroblasts. J Biol Chem 1987; 262: 17690-5.
30. 4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology 1995; 22: 1474-81.
31. Brown K E, Poulos J E, Li L, Soweid A M, Ramm G A, O'Neil R, Britton R S, Bacon B R. Effect of vitamin E supplementation on hepatic fibrogenesis in chronic dietary iron overload. Am J Physiol 1997; 272: G116-23.
32. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Rieken E A, Schuppan D. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 1997; 26: 643-9.
33. Houglum K, Venkataramani A, Lyche K, Chojkier M. A pilot study of d-α-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology 1997; 113: 1069-73.
34. 1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury. A link to tissue fibrosis? Hepatology 1994; 19: 1262-71.
35. Houglum K, Brenner D A, Chojkier M. Inhibition of collagen gene expression by d-α-tocopherol in cultured human fibroblasts. J Clin Invest 1991; 87: 2230-5.
36. Nieto N, Friedman S L, Greenwell P, Cederbaum A I. CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology 1999; 30: 987-96.
37. Nieto N, Friedman S L, Cederbaum A I. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 2002; 35: 62-73.
38. Kelly K A, Youkhana K, Wanker F, Gimble J M. Dimethyl sulfoxide modulates NF-κB and cytokine activation in lipopolysaccharide-treated murine macro-phages. Infect Immun 1994; 62: 3122-8.
39. Essani N A, Fisher M A, Jaeschke H. Inhibition of NF-κB activation by dimethyl sulfoxide correlates with suppression of TNF-α formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock 1997; 7: 90-6.
40. Sprong R C, Aarsman C J, van Oirschot J F, van Asbeck B S. Dimethylthiourea protects rats against gram-negative sepsis and decreases tumor necrosis factor and nuclear factor κB activity. J Lab Clin Med 1997; 129: 470-81.
41. Bruck R, Shirin H, Aeed H, Matas Z, Hochman A, Pines M, Avni Y. Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. J Hepatol 2001; 35: 457-64.
42. Negre-Salvayre A, Reaud V, Hariton C, Salvayre R. Protective effect of α-tocopherolascobic acid and rutin against peroxidative stress induced by oxidized lipoproteins on lymphoid cell lines. Biochem Pharmacol 1991; 42: 450.
43. Hong H J, Wu C C, Yen M H. Pyrrolidine dithiocarbamate improves the septic shock syndromes in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1998; 25: 600-6.
44. Nemeth Z H, Hask G, Vizi E S. Pyrrolidine dithiocarbamate augments IL-10, inhibits TNF-alpha, MIP-alpha, IL-12, and nitric oxide production and protects from the lethal effect of endotoxins. Shock 1998; 10: 49-53.
45. Liu S F, Ye X, Malik A B. In vivo inhibition of nuclear factor kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 1997; 159: 3976-83.
46. Nathens A B, Bitar R, Davreux C, Bujard M, Marshall J C, Dackiw A P, Watson R W, Rotstein O D. Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury. Am J Respir Cell Mol Biol 1997; 17: 608-16.
47. Liu S F, Ye X, Malik A B. Pyrrolidine dithiocarbamate prevents I-kappa B degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol 1999; 55(4): 658-67.
48. Kawai M, Nishikomori R, Jung E Y, Tai G, Yamanaka C, Mayumi M, Heike T. Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. J Immunol 1995; 154: 2333-41.
49. Boyle E M Jr, Kovacich J C, Canty T G Jr, Morgan E N, Chi E, Verrier E D, Pohlman T H. Inhibition of nuclear factor-kappa B nuclear localization reduces human E-selectin expression and the systemic inflammatory response. Circulation 1998; 10(I9 Suppl.): II282-8.
50. Rahman A, Kefer J, Bando M, Niles W D, Malik A B. E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappa B activation. Am J Physiol 1998; 275: L533-44.
51. Elsharkawy A M, Wright M C, Hay R T, Arthur M J, Hughes T, Bahr M J, Degitz K, Mann D A. Persistent activation of nuclear factor-kappa B in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of I kappa B family proteins. Hepatology 1999; 30: 761-9.
52. Lang A, Schoonhoven R, Tuvia S, Brenner D A, Rippe R A. Nuclear factor kappa B in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol 2000; 33: 49-58.
53. Iimuro Y, Bradford B U, Yamashina S, Rusyn I, Nakagami M, Enomoto N, Kono H, Frey W, Forman D, Brenner D, Thurman R G. The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat. Hepatology 2000; 31: 391-8.
54. Thurman R G. Sex-related liver injury due to alcohol involves activation of Kupffer cells by endotoxin. Canad J Gastroenterol 2000; 14: D129-35.
55. Diao J, Garces R, Richardson C D. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 2001; 12: 189-205.
56. Tai D I, Tsai S L, Chang Y H, Huang S N, Chen T C, Chang K S, Liaw Y F. Constitutive activation of nuclear factor kappa B in hepatocellular carcinoma. Cancer 2000; 89: 2274-81.